InvestorsObserver
×
News Home

Evolus Inc (EOLS) Stock: What Does the Chart Say Wednesday?

Wednesday, February 28, 2024 12:23 PM | InvestorsObserver Analysts

Mentioned in this article

Evolus Inc (EOLS) Stock: What Does the Chart Say Wednesday?

Evolus Inc (EOLS) stock is higher by 10.18% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Sentiment Score - ,bullish
Evolus Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on EOLS!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With EOLS Stock Today?

Evolus Inc (EOLS) stock is trading at $14.40 as of 12:19 PM on Wednesday, Feb 28, a decline of -$0.14, or -0.96% from the previous closing price of $14.54. The stock has traded between $14.31 and $14.60 so far today. Volume today is less active than usual. So far 65,255 shares have traded compared to average volume of 712,441 shares. To see InvestorsObserver's Sentiment Score for Evolus Inc click here.

More About Evolus Inc

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary of 900 kilodalton or kDa, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the self-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications that are not reimbursed by any third-party payor, such as Medicaid, Medicare or commercial insurance. Click Here to get the full Stock Report for Evolus Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App